AAV Integration Summary and Implications

AAV Integration RoundtableПодробнее

Model Informed Drug Development Approaches for Immunogenicity Assessments WorkshopПодробнее

AAV case study: 3X titer with integrated clarificationПодробнее

Genetic Therapies for Genetic Diseases: Results and Lessons from Recent SuccessesПодробнее

Long term Expression of AAV mediated FVIII Gene Transfer and Vector Integration EventsПодробнее

Highly accurate HiFi reads for discovery, design, and manufacturing of AAV gene therapyПодробнее

K. I. Berns - Evolution of AAV Vector for Gene TherapyПодробнее

Gene Delivery Tools Webinar | Part 2-AAVПодробнее

Webinar: Development and Use of Adeno Associated (AAV) VectorsПодробнее

Strategies for Accurate, Easy and Fast Quantitation of AAV SerotypesПодробнее

How AAV Gene Transfer Works - Expert AudienceПодробнее

Federico Mingozzi: Assessing and modulating immune responses to AAV vectors in humansПодробнее

Optimizing and Confirming AAV Vector Design with PacBio SequencingПодробнее

The Evolution of Adeno-Associated Virus (AAV) Therapy - Arvind SivashanmugamПодробнее

Biopharma 101: Analysis of Adeno-associated Viral (AAV) Vectors (SCIEX Webinar)Подробнее

Solutions for Viral Vectors: Enabling Platform Approaches to Advance Cell and Gene TherapiesПодробнее

Basics of AAV Gene TherapyПодробнее

Characterization of AAV Vector Persistence After Long-Term Follow-up in the Hemophilia A Dog ModelПодробнее

Adeno-associated virus (AAV) vectors genome integrity & titer analysis with full, empty capsid ratioПодробнее